Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection
Martina Patone, Xue W. Mei, Lahiru Handunnetthi, et al.
Nature Medicine (2021) Vol. 28, Iss. 2, pp. 410-422
Open Access | Times Cited: 544

Showing 1-25 of 544 citing articles:

2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play
Ty J. Gluckman, Nicole M. Bhave, Larry A. Allen, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 17, pp. 1717-1756
Open Access | Times Cited: 309
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents
Øystein Karlstad, Petteri Hovi, Anders Husby, et al.
JAMA Cardiology (2022) Vol. 7, Iss. 6, pp. 600-600
Open Access | Times Cited: 184
COVID-19 vaccination: The road ahead
Daniel M. Altmann, Rosemary J. Boyton
Science (2022) Vol. 375, Iss. 6585, pp. 1127-1132
Closed Access | Times Cited: 180
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex
Martina Patone, Xue W. Mei, Lahiru Handunnetthi, et al.
Circulation (2022) Vol. 146, Iss. 10, pp. 743-754
Open Access | Times Cited: 169
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases
Hui‐Lee Wong, Mao Hu, Cindy Ke Zhou, et al.
The Lancet (2022) Vol. 399, Iss. 10342, pp. 2191-2199
Open Access | Times Cited: 146
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022
Jason P. Block, Tegan K. Boehmer, Christopher B. Forrest, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 14, pp. 517-523
Open Access | Times Cited: 129
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review
Jennifer Pillay, L. Gaudet, Aireen Wingert, et al.
BMJ (2022), pp. e069445-e069445
Open Access | Times Cited: 115
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases
Bettina Heidecker, Noa Dagan, Ran D. Balicer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 11, pp. 2000-2018
Open Access | Times Cited: 107
Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
Stéphane Le Vu, Marion Bertrand, Marie-Joëlle Jabagi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 95
mRNA vaccines for COVID-19 and diverse diseases
Abid Hussain, Haiyin Yang, Jun Zhang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 314-333
Open Access | Times Cited: 81
COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences
Felix Scholkmann, Christian-Albrecht May
Pathology - Research and Practice (2023) Vol. 246, pp. 154497-154497
Open Access | Times Cited: 81
Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis
Navya Voleti, Surya Prakash Reddy, Paddy Ssentongo
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 79
Antiviral Approaches against Influenza Virus
Rashmi Kumari, Suresh D. Sharma, Amrita Kumar, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 1
Open Access | Times Cited: 78
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals
Kristýna Faksová, Donna Walsh, Yannan Jiang, et al.
Vaccine (2024) Vol. 42, Iss. 9, pp. 2200-2211
Open Access | Times Cited: 73
Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins
Janelle Nunez-Castilla, Vitalii Stebliankin, Prabin Baral, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1415-1415
Open Access | Times Cited: 68
Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician
Diana L. Tobler, Alix J. Pruzansky, Sahar Naderi, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 7, pp. 563-570
Open Access | Times Cited: 67
mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids
Kepan Chen, Na Fan, Hai Huang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 39
Open Access | Times Cited: 67
Impact of COVID-19 on Cardiovascular Disease
Ivan Vosko, Andreas Zirlik, Heiko Bugger
Viruses (2023) Vol. 15, Iss. 2, pp. 508-508
Open Access | Times Cited: 63
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
Miriam Echaide, Luisa Chocarro, Ana Bocanegra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5944-5944
Open Access | Times Cited: 52
Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine–associated myocarditis
Anis Barmada, Jon Klein, Anjali Ramaswamy, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 48
COVID-19 vaccination-related myocarditis: a Korean nationwide study
Jae Yeong Cho, Kye Hun Kim, Nuri Lee, et al.
European Heart Journal (2023) Vol. 44, Iss. 24, pp. 2234-2243
Open Access | Times Cited: 41
Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice
Junying Wang, Wenting Lu, Jerry Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Myocarditis associated with COVID-19 vaccination
Alessandra Buoninfante, Arno C. Andeweg, Georgy Genov, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning
Jie Luo, Müge Molbay, Ying Chen, et al.
Nature Biotechnology (2025)
Open Access | Times Cited: 1
Uptake and safety of Sotrovimab for prevention of severe COVID-19 in a cohort and self-controlled case series study
Martina Patone, Andrew JHL Snelling, Holly Tibble, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top